These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2. Zhang A; Meng L; Wang Q; Xi L; Chen G; Wang S; Zhou J; Lu Y; Ma D Oncol Rep; 2006 Apr; 15(4):831-6. PubMed ID: 16525667 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines. Avramis IA; Christodoulopoulos G; Suzuki A; Laug WE; Gonzalez-Gomez I; McNamara G; Sausville EA; Avramis VI Cancer Chemother Pharmacol; 2002 Dec; 50(6):479-89. PubMed ID: 12451475 [TBL] [Abstract][Full Text] [Related]
9. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis. Bae DG; Kim TD; Li G; Yoon WH; Chae CB Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646 [TBL] [Abstract][Full Text] [Related]
10. Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model. Bhuvaneswari R; Yuen GY; Chee SK; Olivo M Lasers Surg Med; 2011 Sep; 43(7):651-62. PubMed ID: 22057493 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Li Z; Van Bergen T; Van de Veire S; Van de Vel I; Moreau H; Dewerchin M; Maudgal PC; Zeyen T; Spileers W; Moons L; Stalmans I Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5217-25. PubMed ID: 19474408 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2. Kernt M; Thiele S; Neubauer AS; Koenig S; Hirneiss C; Haritoglou C; Ulbig MW; Kampik A Retina; 2012 Sep; 32(8):1652-63. PubMed ID: 22466477 [TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977 [TBL] [Abstract][Full Text] [Related]
14. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related]
15. Direct effect of bevacizumab on glioblastoma cell lines in vitro. Simon T; Coquerel B; Petit A; Kassim Y; Demange E; Le Cerf D; Perrot V; Vannier JP Neuromolecular Med; 2014 Dec; 16(4):752-71. PubMed ID: 25113866 [TBL] [Abstract][Full Text] [Related]
16. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104 [TBL] [Abstract][Full Text] [Related]
17. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602 [TBL] [Abstract][Full Text] [Related]
18. Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A. Jia Z; Zhang J; Wei D; Wang L; Yuan P; Le X; Li Q; Yao J; Xie K Cancer Res; 2007 May; 67(10):4878-85. PubMed ID: 17510417 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Deryugina EI; Soroceanu L; Strongin AY Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713 [TBL] [Abstract][Full Text] [Related]
20. Autocrine vascular endothelial growth factor/vascular endothelial growth factor receptor-2 growth pathway represents a cyclooxygenase-2-independent target for the cyclooxygenase-2 inhibitor NS-398 in colon cancer cells. Kim SJ; Seo JH; Lee YJ; Yoon JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS Oncology; 2005; 68(2-3):204-11. PubMed ID: 16015035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]